S Yusuf Selected Research

S Yusuf Research Topics

Disease

24	Heart Failure 04/2013 - 01/2000
22	Myocardial Infarction 01/2012 - 01/2000
17	Stroke (Strokes) 05/2015 - 01/2000
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 07/2000
9	Hypertension (High Blood Pressure) 07/2016 - 07/2000
9	Glucose Intolerance 09/2014 - 07/2000
8	Acute Coronary Syndrome 05/2004 - 06/2000
7	Hemorrhage 01/2018 - 06/2000
7	Unstable Angina 05/2004 - 01/2000
6	Type 2 Diabetes Mellitus (MODY) 09/2014 - 09/2006
5	Vascular Diseases (Vascular Disease) 01/2023 - 01/2000
5	Obesity 08/2015 - 10/2001
5	Atrial Fibrillation 05/2012 - 09/2001
4	Coronary Disease (Coronary Heart Disease) 02/2010 - 01/2000
4	Atherosclerosis 02/2010 - 01/2000
4	Left Ventricular Dysfunction 07/2001 - 01/2000
4	Infarction (Infarctions) 01/2001 - 05/2000
2	Abdominal Obesity 08/2015 - 10/2001
2	Anemia 05/2015 - 01/2014
2	Infections 01/2014 - 03/2001
2	Overweight 02/2013 - 02/2010
2	Neoplasms (Cancer) 01/2012 - 01/2000
2	Renal Insufficiency (Renal Failure) 05/2008 - 04/2001
2	Hypotension (Low Blood Pressure) 06/2000 - 04/2000
1	Leiomyosarcoma 01/2020
1	Albuminuria 07/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2015
1	Parasitemia 01/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2012
1	Body Weight (Weight, Body) 11/2011
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2010
1	Kidney Diseases (Kidney Disease) 05/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2007
1	Insulin Resistance 09/2006

Drug/Important Bio-Agent (IBA)

14	Ramipril (Altace)FDA LinkGeneric 11/2010 - 01/2000
13	Glucose (Dextrose)FDA LinkGeneric 09/2014 - 08/2000
13	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2008 - 01/2000
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2010 - 06/2000
8	Clopidogrel (Plavix)FDA Link 02/2010 - 12/2000
6	Rosiglitazone (Avandia)FDA Link 09/2014 - 09/2004
5	LDL CholesterolIBA 02/2010 - 07/2000
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2007 - 01/2000
4	Dabigatran FDA Link 01/2018 - 11/2011
4	CreatinineIBA 07/2015 - 04/2001
4	candesartanIBA 01/2007 - 01/2000
4	Heparin (Liquaemin)FDA LinkGeneric 01/2002 - 06/2000
4	Vitamin E FDA LinkGeneric 07/2001 - 01/2000
3	SodiumIBA 01/2019 - 04/2013
3	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 12/2000
3	AnticoagulantsIBA 05/2015 - 06/2006
3	CholesterolIBA 01/2010 - 07/2000
3	HDL CholesterolIBA 01/2008 - 07/2000
3	HirudinsIBA 01/2002 - 09/2000
3	Fibrinogen (Factor I)FDA Link 10/2001 - 07/2000
3	Plasminogen Activators (Plasminogen Activator)IBA 10/2001 - 07/2000
2	Vitamin D FDA LinkGeneric 01/2023 - 01/2012
2	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2012 - 09/2006
2	LipidsIBA 02/2010 - 01/2005
2	Insulin (Novolin)FDA Link 02/2010 - 08/2000
2	Telmisartan (Micardis)FDA Link 09/2008 - 03/2007
2	Irbesartan FDA LinkGeneric 06/2006 - 06/2006
2	PlacebosIBA 07/2001 - 02/2001
2	Radioisotopes (Radionuclides)IBA 01/2001 - 08/2000
2	HomocysteineIBA 11/2000 - 07/2000
2	Triglycerides (Triacylglycerol)IBA 11/2000 - 07/2000
2	Lipoprotein(a)IBA 11/2000 - 07/2000
2	candesartan cilexetil (Amias)FDA Link 04/2000 - 01/2000
1	phenithionate (7720)IBA 08/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2014
1	ThiazolidinedionesIBA 09/2014
1	AdiponectinIBA 09/2014
1	AdipokinesIBA 09/2014
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2014
1	Lactose FDA LinkGeneric 01/2014
1	SaltsIBA 04/2013
1	CarbohydratesIBA 02/2013
1	Pioglitazone (Actos)FDA Link 01/2012
1	Cholecalciferol (Vitamin D3)FDA Link 01/2012
1	Hemoglobins (Hemoglobin)IBA 11/2011
1	Thrombin FDA Link 11/2011
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	ApolipoproteinsIBA 02/2010
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2010
1	Fondaparinux (Arixtra)FDA Link 02/2010
1	Enoxaparin (Lovenox)FDA LinkGeneric 02/2010
1	Atenolol (Tenormin)FDA LinkGeneric 04/2009
1	Simvastatin (Zocor)FDA LinkGeneric 04/2009
1	ThiazidesIBA 04/2009
1	Angiotensin Receptor AntagonistsIBA 09/2008
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2007
1	2,6-dinitrotoluene (DNT)IBA 04/2006

Therapy/Procedure

10	Therapeutics 11/2011 - 05/2000
2	Contraindications 06/2006 - 09/2000
2	Thrombolytic Therapy 04/2006 - 01/2001
2	Percutaneous Coronary Intervention 01/2002 - 07/2001
1	Neoadjuvant Therapy 01/2020
1	Secondary Prevention 01/2019
1	Drug Therapy (Chemotherapy) 02/2010
1	Transjugular Intrahepatic Portasystemic Shunt 04/2009